|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 February 2016 |
|
Main ID: |
NCT01855516 |
|
Date of registration:
|
13/05/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin
|
|
Scientific title:
|
Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin: Comparison of a 2 Times Per Day Versus a 3 Times Per Day Dosage. |
|
Date of first enrolment:
|
September 2013 |
|
Target sample size:
|
83 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01855516 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Nathalie Massicotte, MD, FRCPC |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Centre hospitalier de l'Université de Montréal (CHUM) |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients undergoing an elective surgery by thoracoscopy requiring antithrombotic
prophylaxis
- Anticipated duration of hospital stay of at least 3 days
Exclusion Criteria:
- Pre-existing coagulopathy
- Severe renal failure
- Known allergy to heparin
- History of heparin induced thrombocytopenia
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Thrombosis
|
|
Intervention(s)
|
|
Drug: Heparin
|
|
Primary Outcome(s)
|
|
Proportion of abnormal partial thromboplastin time values 72 hours after the administration of the first dose of antithrombotic prophylaxis in patients receiving UFH 5000 U 2 times a day versus 3 times a day following surgery.
[Time Frame: 3 days after surgery]
|
|
Secondary ID(s)
|
|
NM2013-001
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|